Crossmark

Verification of foetal Down syndrome biomarker proteins in maternal plasma and applications in prenatal screening for Down syndrome

Crossref DOI link: https://doi.org/10.1186/s41231-018-0028-x

Published Online: 2018-11-17

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sui, Weiguo

Gan, Qing

Gong, Wei Wei

Wei, Xiaolian

Ou, Minglin

Tang, Donge

Jing, Huanyun

Lin, Hua

Zhang, Yue

Dai, Yong https://orcid.org/0000-0002-6840-9158
Funding

Funding for this research was provided by:

the Scientific and Technological Research of Guilin Research and Technology Development Plan Project Contract (No. 20170109-34)

Science and Technology Planning Project of Guangdong Province, China (No. 2017B020209001)

Natural Science Foundation of Guangdong Province, China (No. 2017A030310629)
License Information

Text and Data Mining valid from 2018-11-17
More Information

Article History

Received: 16 August 2018

Accepted: 8 November 2018

First Online: 17 November 2018

Ethics approval and consent to participate

: This study was undertaken with the approval of the Institutional Ethical Board Shenzhen People<i>’</i>s Hospital (Shenzhen, China). Written informed consent was obtained from all pregnant women and children participated.

: Not applicable.

: The authors declare that they have no competing interests in this section.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.